Günther, S

Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. [electronic resource] - Journal of virology Dec 1996 - 8318-31 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0022-538X

10.1128/JVI.70.12.8318-8331.1996 doi


Amino Acid Sequence
Base Sequence
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
Binding Sites
CCAAT-Enhancer-Binding Proteins
Culture Media
DNA, Viral--metabolism
DNA-Binding Proteins--metabolism
Enhancer Elements, Genetic
Gene Expression Regulation, Viral
Genetic Variation
Hepatitis B--blood
Hepatitis B Core Antigens--genetics
Hepatitis B Surface Antigens--genetics
Hepatitis B virus--genetics
Hepatocyte Nuclear Factor 1
Hepatocyte Nuclear Factor 1-alpha
Hepatocyte Nuclear Factor 1-beta
Hepatocyte Nuclear Factor 4
Humans
Immunosuppression Therapy
Kidney Transplantation--adverse effects
Liver Diseases--blood
Molecular Sequence Data
Mutation
Nuclear Proteins--metabolism
Phosphoproteins--metabolism
Promoter Regions, Genetic
Protein Biosynthesis
RNA Precursors
Trans-Activators--genetics
Transcription Factors--metabolism
Viral Regulatory and Accessory Proteins
Virion